GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » E10

X Bioscience PCL (BKK:XBIO-W7) E10 : ฿0.00 (As of Mar. 2025)


View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

X Bioscience PCL's adjusted earnings per share data for the three months ended in Mar. 2025 was ฿0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ฿0.00 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average E10 Growth Rate was 14.30% per year. During the past 5 years, the average E10 Growth Rate was 4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of X Bioscience PCL was 14.30% per year. The lowest was -3.80% per year. And the median was -1.70% per year.

As of today (2025-07-23), X Bioscience PCL's current stock price is ฿0.02. X Bioscience PCL's E10 for the quarter that ended in Mar. 2025 was ฿0.00. X Bioscience PCL's Shiller PE Ratio of today is .


X Bioscience PCL E10 Historical Data

The historical data trend for X Bioscience PCL's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL E10 Chart

X Bioscience PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

X Bioscience PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of X Bioscience PCL's E10

For the Food Distribution subindustry, X Bioscience PCL's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


X Bioscience PCL's Shiller PE Ratio Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, X Bioscience PCL's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where X Bioscience PCL's Shiller PE Ratio falls into.


;
;

X Bioscience PCL E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, X Bioscience PCL's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0/134.9266*134.9266
=0.000

Current CPI (Mar. 2025) = 134.9266.

X Bioscience PCL Quarterly Data

per share eps CPI Adj_EPS
201506 0.152 100.684 0.204
201509 -7.386 100.392 -9.927
201512 -35.525 99.792 -48.032
201603 -7.358 100.470 -9.881
201606 -2.697 101.688 -3.579
201609 -1.410 101.861 -1.868
201612 -6.887 101.863 -9.122
201703 -0.938 102.862 -1.230
201706 1.765 103.349 2.304
201709 0.352 104.136 0.456
201712 -19.104 104.011 -24.782
201803 -0.059 105.290 -0.076
201806 0.392 106.317 0.497
201809 0.022 106.507 0.028
201812 -0.012 105.998 -0.015
201903 -0.392 107.251 -0.493
201906 -0.392 108.070 -0.489
201909 3.645 108.329 4.540
201912 -3.001 108.420 -3.735
202003 -0.643 108.902 -0.797
202006 -0.572 108.767 -0.710
202009 -0.025 109.815 -0.031
202012 -2.894 109.897 -3.553
202103 -0.071 111.754 -0.086
202106 -0.087 114.631 -0.102
202109 -0.085 115.734 -0.099
202112 -0.081 117.630 -0.093
202203 -0.105 121.301 -0.117
202206 -0.133 125.017 -0.144
202209 -0.114 125.227 -0.123
202212 -0.316 125.222 -0.340
202303 -0.038 127.348 -0.040
202306 -0.029 128.729 -0.030
202309 -0.029 129.860 -0.030
202312 -0.074 129.419 -0.077
202403 -0.048 131.776 -0.049
202406 -0.038 132.554 -0.039
202409 -0.076 133.029 -0.077
202412 0.000 133.157 0.000
202503 0.000 134.927 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


X Bioscience PCL  (BKK:XBIO-W7) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


X Bioscience PCL E10 Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


X Bioscience PCL Business Description

Traded in Other Exchanges
Address
Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines